Shanghai Kaibao Pharmaceutical CO.,Ltd reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 800.01 million compared to CNY 794.95 million a year ago. Revenue was CNY 800.01 million compared to CNY 794.95 million a year ago.

Net income was CNY 118.61 million compared to CNY 115.5 million a year ago. Basic earnings per share from continuing operations was CNY 0.1134 compared to CNY 0.1104 a year ago. Diluted earnings per share from continuing operations was CNY 0.1134 compared to CNY 0.1104 a year ago.